Newmars Group team took a part at the Eurasian Cancer Screening Conference 2018 on May 17-18, 2018 in Minsk, Belarus. The exchange of experience between countries, discussion of problems and solutions, as well as the creation of the unified strategy and the improvement of the already implemented approaches in the development and implementation effective screening programs at the interstate level were the main topic of the conference.
World known experts in cancer screening shared their experience, evidence and expertise among members of the meeting to improve screening implementation. Keynote reports included most challenging problems of this region and issues surrounding screening programs dedicated to breast, cervical, colorectal and prostate cancers.
Within the framework of the exhibition, Newmars Group demonstrated the advanced capabilities of LuViva Cervical Scan, based on the method of computerized spectral fluorescence analysis. Which allows determining the risk of developing cervical cancer in the earliest stages without any use of invasive intervention.
LuViva Cervical Scan aroused deep interest with a positive feedback from physicians of the need for advanced methods in the routine practice of the early oncological diseases detection.
We are proud to inform you that on December 12, 2017 held a successful delivery and commissioning of the Aviator high-level transport incubator for the National Medical Research Center named after Almazov.
This equipment includes not only a multimodal transport ventilator for newborns, but also additional possibilities such as TXP-2D high-frequency ventilation and AeroNOx nitric oxide delivery system.
The AeroNOx provides a controlled concentration of nitric oxide by delivering a constant flow of nitric oxide into the inspiratory limb of a mechanical ventilator.
Aviator transport incubator will provide intensive care for newborns at high risk (premature babies, including those with extremely low body weight and very low body weight, newborns with acute respiratory failure that require traditional convective ventilation and / or high-frequency oscillatory / jet / percussion ventilation, and / or non-invasive CPAP and / or non-invasive ventilation of the lungs, under controlled environmental conditions.
All the equipment of Aviator transport incubator, including the TXP-2D and AeroNOx, are designed for operation under vibration and overload conditions, which makes it compatible for both air and ground transport.
As befits Newmars Group Rus team under the leadership of G.M. Andrei Pankratov conducted end-users training for doctors with a demo of equipment capabilities.
On March 24-25, 2017 in Hajdúszoboszló, Hungary, the 22nd scientific meeting of the section of cervical pathology of the Hungarian Society of Obstetrics and Gynecology took place. It was devoted to the topical issues of the application of advanced methods of cervical screening and diagnosis of cervical disease. Chief leaders, leading experts and practicing doctors from various clinics not only from Hungary, but also from Russia and the United States took part in the meeting. As part of the event, Newmars Group presented advanced technology LuViva, a computerized spectroscopic fluorescent scanner for the diagnosis of gynecological diseases. LuViva allows determining the risks of cervical cancer development with a high accuracy.
The world experience of using unique equipment shared by specialists from Russia and the United States was included as at the scientific program of lectures, so at the open discussion platforms: a round table was made for specialists with demonstration of equipment capabilities and clinical research results.
As the result of the event, the advanced equipment will protect women's health at the leading gynecological clinic in Debrecen, Hungary.
The Newmars Group continues to expand in Russia. In January 2016 the Company entered to North-West region market to supply medical equipment and consumables.
We are pleased to announce that Newmars Group trademark was registered in the European Union.
Our company has signed an agreement with Guided Therapeutics Inc. (USA). Based on this agreement, we represent LuViva® Advanced Cervical Scan within Hungary and Russia. LuViva ® Advanced Cervical Scan uses biophotonics to scan cervix for any type of dysplasia. LuViva ® scan has to be used before colposcopy and it is position as follow-up or recall procedure to triage the disease state of women with abnormal cytology or other risk factors.
The Newmars Group continues expanding within the European Union.
We have just opened a new office in Vilnius, Lithuania. We are introducing our new developments in the Baltic region.